Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals | Zendy

Conan MacDougall | Zendy; James Patrick Powell | Zendy; C. K. Johnson | Zendy; Michael B. Edmond | Zendy; Ronald E. Polk | Zendy

Open Access

Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals

Author(s) -

Conan MacDougall,

James Patrick Powell,

C. K. Johnson,

Michael B. Edmond,

Ronald E. Polk

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/432056

Subject(s) - medicine , staphylococcus aureus , population , microbiology and biotechnology , escherichia coli , methicillin resistant staphylococcus aureus , environmental health , bacteria , biology , biochemistry , gene , genetics

Fluoroquinolones are widely prescribed in hospitals and the community. Previous studies have shown associations between fluoroquinolone use and isolation of fluoroquinolone-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA). We performed an ecologic-level study to determine whether variability in hospital percentages of fluoroquinolone-resistant E. coli and MRSA were associated with fluoroquinolone use in hospitals and their surrounding communities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research